Differentiating AFib RVR from Ventricular Tachycardia
When faced with a wide-complex tachycardia, assume ventricular tachycardia until proven otherwise—this approach prioritizes patient safety and prevents the potentially fatal error of treating VT as AFib with aberrancy.
Critical ECG Differentiation Features
AFib RVR Characteristics:
- Irregularly irregular rhythm is the hallmark finding
- Absent P waves, replaced by fibrillatory waves
- Variable R-R intervals with no discernible pattern
- QRS typically narrow (<120 ms) unless pre-existing bundle branch block or aberrant conduction
- If wide-complex: look for underlying bundle branch block pattern that remains consistent
Ventricular Tachycardia Characteristics:
- Regular or slightly irregular rhythm (unlike AFib's chaotic irregularity)
- Wide QRS complexes (>120 ms)
- AV dissociation (independent P waves marching through at different rate)
- Fusion or capture beats (pathognomonic for VT)
- Extreme axis deviation
- Concordance in precordial leads (all positive or all negative)
- Brugada criteria: absence of RS complex in all precordial leads strongly suggests VT
Critical Clinical Context
Hemodynamic stability assessment comes first:
- Hypotension, altered mental status, chest pain, pulmonary edema, or shock → immediate synchronized cardioversion regardless of rhythm 1
- In pre-excited AFib (WPW syndrome) with very rapid rates: immediate electrical cardioversion to prevent ventricular fibrillation 2
Management Algorithm
For AFib RVR (Once Confirmed):
Hemodynamically Unstable:
- Immediate R-wave synchronized cardioversion 1
- Do NOT delay for pharmacologic attempts
Hemodynamically Stable:
First-line rate control (Class I recommendation):
If heart failure present:
- IV digoxin or amiodarone (avoid beta-blockers and calcium channel blockers in decompensated HF) 1
Critical contraindication:
For Ventricular Tachycardia (Once Confirmed):
Hemodynamically Unstable:
- Immediate unsynchronized defibrillation if pulseless
- Immediate synchronized cardioversion if pulse present 7
Hemodynamically Stable (Monomorphic VT):
- IV amiodarone is preferred first-line agent
- IV procainamide is alternative
- Avoid beta-blockers and calcium channel blockers—these are for AFib, not VT
- Prepare for cardioversion if pharmacologic therapy fails
Common Pitfalls to Avoid
The "wide-complex tachycardia" trap: Treating presumed "AFib with aberrancy" with AV nodal blockers when it's actually VT can cause hemodynamic collapse. When in doubt, treat as VT.
The WPW catastrophe: Giving digoxin, diltiazem, or verapamil to pre-excited AFib accelerates conduction down the accessory pathway, potentially causing ventricular fibrillation 2, 5. Look for delta waves on prior ECGs or very rapid rates (>250 bpm).
Ignoring irregularity: If the rhythm is irregularly irregular, it's almost certainly AFib (or atrial flutter with variable block), not VT. VT is regular or only slightly irregular 8.
Calcium channel blockers in heart failure: IV diltiazem or verapamil in decompensated heart failure with AFib can worsen hemodynamics—use digoxin or amiodarone instead 5.
Key Diagnostic Pearls
- Irregularity rules out most VT: The chaotic irregularity of AFib is distinctive
- AV dissociation proves VT: Independent atrial activity marching through confirms ventricular origin
- Prior ECG comparison is invaluable: Pre-existing bundle branch block suggests AFib with aberrancy rather than VT
- Age and structural heart disease matter: VT is more likely in older patients with prior MI or cardiomyopathy; idiopathic VT occurs in younger patients with structurally normal hearts 7, 8
The bottom line: When rhythm diagnosis is uncertain with a wide-complex tachycardia, default to VT management—this is the safest approach that minimizes mortality risk.